久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • AbbVie halts phase III TAHOE trial of Rova-T for SCLC pharmaceutical-technology
    December 10, 2018
    Following advice from an independent data monitoring committee, biopharma company AbbVie has ceased enrolment in its TAHOE trial evaluating Rovalpituzumab Tesirine.....
PharmaSources Customer Service